Skip to main content
. 2022 Jan 13;12:672. doi: 10.1038/s41598-021-04349-7

Table 4.

Factors associated with mortality and neurological impairment due to community-acquired bacterial meningitis, including time to antibiotics using patients matched for age and sex by propensity scoring.

Covariates  < / > 1 ha  < / > 2 h  < / > 3 h  < / > 4 h  < / > 5 h
Univariate Multivariable Univariate Multivariable Univariate Multivariable Univariate Multivariable Univariate Multivariable
Mortality n = 226 n = 362 n = 362 n = 324 n = 286
Time to antibiotics 1.64 (0.81–3.23) 1.02 (1.02–1.02) 2.43 (1.43–4.12) 2.29 (1.28–4.09) 2.93 (1.67–5.12) 2.78 (1.49–6.16) 3.07 (1.81–5.20) 3.77 (2.49–5.71) 2.65 (1.54–4.54) 3.11 (1.47–6.59)
Age (years) 1.06 (1.03–1.08) 1.05 (1.03–1.07) 1.05 (1.03–1.07) 1.05 (1.04–1.05) 1.05 (1.03–1.07) 1.05 (1.04–1.06) 1.06 (1.03–1.08) 1.06 (1.04–1.07) 1.05 (1.03–1.08) 1.05 (1.05–1.06)
Comorbidity 1.30 (0.64–2.64) 1.92 (1.15–3.19) 1.73 (1.24–2.42) 1.61 (0.99–2.60) 1.37 (1.12–1.66) 1.69 (1.01–2.75) 1.46 (0.87–2.46)
Impaired consciousnessb 3.83 (1.58–9.27) 3.12 (1.85–5.28) 3.76 (1.98–7.15) 2.95 (2.34–3.73) 2.45 (1.41–4.26) 2.37 (1.89–2.96) 2.34 (1.30–4.18) 2.66 (2.21–3.21) 2.15 (1.19–3.86) 2.37 (1.94–2.90)
Steroid administration 0.60 (0.03–1.27) 0.65 (0.37–1.15) 0.66 (0.55–0.80) 0.60 (0.36–0.99) 0.65 (0.52–0.81) 0.60 (0.35–1.03) 0.64 (0.51–0.79) 0.50 (0.27–0.89) 0.54 (0.40–0.73)
Neurological impairment n = 180 n = 276 n = 263 n = 229 n = 200
Time to antibiotics 1.62 (0.84–3.14) 1.76 (0.57–3.56) 1.49 (0.87–2.54) 1.45 (0.83–2.53) 1.60 (0.94–2.72) 1.79 (1.03–3.14) 1.44 (0.83–2.51) 1.62 (0.92–2.87) 1.69 (0.94–3.06) 1.87 (1.02–3.44)
Age (years) 1.05 (1.02–1.07) 1.05 (1.03–1.07) 1.03 (1.01–1.05) 1.03 (1.01–1.05) 1.02 (1.00–1.03) 1.01 (0.99–1.03) 1.00 (0.99–1.03)
Comorbidity 1.30 (0.64–2.64) 1.71 (1.00–2.92) 1.74 (1.02–2.99) 1.76 (1.00–3.11) 1.40 (0.75–2.49)
Impaired consciousness 3.83 (1.58–9.28) 1.75 (0.98–3.11) 2.25 (1.25–4.04) 2.79 (1.51–5.18) 1.99 (1.10–3.61) 2.18 (1.19–4.00) 1.92 (1.02–3.62) 2.12 (1.11–4.08)
Steroid administration 0.56 (0.27–1.14) 0.46 (0.27–0.81) 0.47 (0.26–0.83) 0.51 (0.30–0.89) 0.46 (0.26–0.52) 0.61 (0.34–1.07) 0.50 (0.27–0.92)

aLess than or greater than hourly interval to the administration of effective antibacterial therapy.

bImpaired consciousness at presentation to hospital.